A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug ...

Students have access to a wide range of substance abuse resources that include educational opportunities, skill development and intervention support, accompanied by regular programming promoting a ...

A study has found that glucagon-like peptide-1 (GLP-1) class obesity treatments, such as ‘Wegovy,’ may slow the rate of ...

Popular weight loss drugs, like semaglutide (Ozempic, Wegovy) and liraglutide (Victoza), have transformed the way doctors treat diabetes and obesity. Now research suggests these meds — part of a class ...

Weight-loss drugs like Wegovy and Zepbound are transforming the health of millions of people—and a new study hints that even more could benefit from the drugs’ other effects on the body. A study ...

New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and drug addiction. A widely used group of medications originally developed to ...

A Pacific Northwest program that helps people overcome drug and alcohol addiction is this month's One Class at a Time recipient of $1,000 from Mid Oregon Credit Union. Bola Gbadebo visited the Central ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

A new study showed that semaglutide may help with alcohol use disorder Steve Christo - Corbis/Corbis via Getty; Getty A new study (the first clinical trial of its kind) has shown that the GLP-1 ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced it will review the use of medicines containing sodium oxybate, a drug used in narcolepsy, ...